Safety and Efficacy of Neuroform3TM for Intracranial Aneurysm Treatment (SENAT)

Inclusion Criteria:

• 18 year's old patient or above.
• every patient suffering from an un-ruptured or ruptured aneurysm, for whom the endovascular treatment approach using the Neuroform3TM stent is considered by the therapeutic team in charge.
• patient who has given his consent to participate to the study and to get his anonymized data collected

Exclusion Criteria:

• patient with dissecting or fusiform aneurysm
• treatment of several aneurysms in the same procedure, except adjacent aneurysm treated by the same stent
• severe vasospasm
• aneurysm associated with an arterio-venous malformation
• use of another Neuroform3TM stent
• woman pregnant or nursing
• patients not likely to be followed upon (living abroad)
• people protected by justice (safeguard of law, supervision or trusteeship)
• patient unsuitable to the anti-thrombotic and/or to anticoagulants therapies